CARDIAC DIMENSIONS HIRES GRETCHEN GARY AS VICE PRESIDENT OF GLOBAL THERAPY DEVELOPMENT March 6, 2020
New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate in Patients with Functional Mitral Regurgitation February 25, 2020
REDUCE FMR Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure September 12, 2019
View more Press Releases
New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting June 13, 2019
New Data Confirms Cardiac Dimensions’ Carillon® System Provides Acute Hemodynamic Efficacy in Patients with Functional Mitral Regurgitation April 26, 2019
Cardiac Dimensions Announces DRG Reimbursement Code for Carillon® Mitral Contour System® in Germany October 18, 2018
In Randomized Blinded Study, the Carillon Mitral Contour System Catheter-Based Treatment Meets Endpoint for Reduction in Regurgitant Volume September 24, 2018
Cardiac Dimensions Announces Late-Breaking Data to be Presented at The Transcatheter Cardiovascular Therapeutics Conference (TCT) 2018 September 20, 2018
Cardiac Dimensions Announces the Randomization of its First Patient in the U.S. Pivotal Trial – The CARILLON Trial September 19, 2018
The #CarillonMitralContourSystem Benchtop-Model is one of the favorite tools designed to show the cinching effect of the technology.
#ReshapingTheCourseOfHeartFailure™ #MedTech #cardiac #interventionalcardiology #healthcareprofessionals #healthtech #heartfailure #FMR https://t.co/9tWPpewL0b
Welcome Psimitis S.A. from Athens, Greece in partnering with the @Carillon_CDI Team to help improve the quality of life of patients suffering with #FMR and #HeartFailure.
#ReshapingTheCourseOfHeartFailure™ #MedTech #cardiac #interventionalcardiology #healthcareprofessionals https://t.co/FiCipoyZ7I